|
Sermorelin
resources
|
|
|
|
|
|
DRUG INFO
Sermorelin
Drug Name:
Sermorelin
Indication: For treatment of dwarfism, prevention of HIV-induced weight loss
Pharmacology: Used in the treatment of children with growth hormone deficiency or growth failure. Geref increases plasma growth hormone (GH) concentration by stimulating the pituitary gland to release GH. Geref is similar to the full-length native hormone (44 residues) in its ability to stimulate GH secretion in humans.
Mechanism Of Action: Binds to the growth hormone releasing hormone receptor and mimics native GRF in its ability to stimulate growth hormone secretion.
Drug Category: Anabolic Agents; Hormone replacement
Brand Names/Synonyms: Geref; Geref (Serono Pharma)
Dosage Forms: Not Available
Absorption: Not Available
Interactions: Not Available
Chemical IUPAC Name: Human growth hormone-releasing hormone fragment
Chemical Formula: C154H253N45O45S1
Half Life: 11-12 min
Drug Type: Approved Drug
# Accession No: BIOD00033
CAS Registry Number: 86168-78-7
|
|
|
|
|
|
Sermorelin News
(When available)
Gran who died trying to save boy laid to rest Dec 13, 2005
Independent Online, Her son, Fritz, said his mother was to be buried at the Pretoria East cemetery. The funeral service was held at the Ned Geref Kerk Waterkloof. ...
|
|
|
